These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1259760)

  • 1. Synthesis of platelet-aggregating factor by human platelet microsomes.
    Ho PP; Walters CP; Hermann RG
    Biochem Biophys Res Commun; 1976 Mar; 69(1):218-24. PubMed ID: 1259760
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of aspirin and indomethacin on the platelet contractile wave.
    Gerrard JM; White JG
    Am J Pathol; 1976 Mar; 82(3):513-26. PubMed ID: 1258974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding of bovine platelet aggregating factor to human platelets.
    Brown JE; Thuy LP
    Thromb Res; 1981 Apr 1-15; 22(1-2):41-51. PubMed ID: 7292446
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of halofenate--free acid on aggregation--the release reaction, coagulant activity, and lipid metabolism of human platelets.
    Huzoor-Akbar ; Ardlie NG
    Thromb Haemost; 1977 Oct; 38(3):612-9. PubMed ID: 579507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human platelet stimulation by acetyl glyceryl ether phosphorylcholine.
    McManus LM; Hanahan DJ; Pinckard RN
    J Clin Invest; 1981 Mar; 67(3):903-6. PubMed ID: 7204562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
    Jobin F
    Union Med Can; 1976 Aug; 105(8):1159-73. PubMed ID: 10662
    [No Abstract]   [Full Text] [Related]  

  • 7. Human platelet activation by an alkylacetyl analogue of phosphatidylcholine.
    Rao GH; Schmid HH; Reddy KR; White JG
    Biochim Biophys Acta; 1982 Apr; 715(2):205-14. PubMed ID: 6280777
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative evaluation of the inhibitory effects of aspirin-like drugs on prostaglandin production by human platelets and synovial tissue.
    Patrono C; Ciabattoni G; Greco F; Grossi-Belloni D
    Adv Prostaglandin Thromboxane Res; 1976; 1():125-31. PubMed ID: 826138
    [No Abstract]   [Full Text] [Related]  

  • 9. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
    Smith JB; Ingerman CM; Silver MJ
    J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
    Kobzar G; Mardla V; Samel N
    Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by aspirin of release of antiheparin activity from human platelets.
    Youssef AH; Barkhan P
    Br Med J; 1969 Aug; 3(5667):394-6. PubMed ID: 5797782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation.
    Glass DB; Gerrard JM; Townsend D; Carr DW; White JG; Goldberg ND
    J Cyclic Nucleotide Res; 1977 Feb; 3(1):37-44. PubMed ID: 191476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of pH on platelet and coagulation factor activities.
    Chaimoff C; Creter D; Djaldetti M
    Am J Surg; 1978 Aug; 136(2):257-9. PubMed ID: 28678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin at therapeutic concentrations does not affect 5-hydroxytryptamine uptake by platelets.
    Drummond AH; MacIntyre DE; Olverman HJ
    Br J Pharmacol; 1977 Apr; 59(4):661-2. PubMed ID: 858010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a new non-steroidal anti-inflammatory agent, sulindac, on platelet function.
    Green D; Given KM; Ts'ao C; Whipple JP; Rossi EC
    Thromb Res; 1977 Feb; 10(2):283-9. PubMed ID: 322358
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemistry, measurement, and clinical significance of platelet specific proteins.
    de Boer AC; Genton E; Turpie AG
    Crit Rev Clin Lab Sci; 1982; 18(2):183-211. PubMed ID: 6185275
    [No Abstract]   [Full Text] [Related]  

  • 17. Release of biologically active substances from non-aggregating human platelets.
    Lofts FJ; Moore PK
    Eur J Pharmacol; 1982 May; 80(2-3):203-7. PubMed ID: 7106175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A platelet procoagulant activity associated with platelet shape change.
    Ehrman M; Toth E; Frojmovic M
    J Lab Clin Med; 1978 Sep; 92(3):393-401. PubMed ID: 681825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
    Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK
    Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
    Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
    Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.